RxDoctor Payments Data

Ella Ariza-Heredia, MD

Infectious Disease · Houston, TXNPI 1609024421

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in TX, where the typical reported total is $451.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$290,437in research payments, 2019–2025

Across 139 payments — averaging $2089.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$290K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 576 infectious disease providers in Texas.

See all infectious disease providers in Texas

Medicare billing

Part B allowed, 2024
$31,685
Medicare patients
167
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate22$441
Minocycline Hcl12$352
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$260
Azithromycin14$197

Paid to pharmacies, not to this prescriber.

Other infectious disease in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →